Impact (REF3a/b)
5 - Biological Sciences
University of Oxford
Impact template (REF3a)
Download template (187K)
All impact case studies
Download all case studies (3.5MB)
Individual case studies
UOA05-01: A novel vaccination strategy to safeguard the Ethiopian wolf from extinction (88K)
UOA05-03: Saving the world’s forests: maintaining biodiversity alongside economic development (164K)
UOA05-04: Miglustat: the first oral treatment for rare but devastating lysosomal storage disorders (155K)
UOA05-05: Glycobiology platforms: enabling technologies for the biopharmaceutical industry (168K)
UOA05-06: Effective treatment of chronic lymphocytic leukaemia (150K)
UOA05-07: A paradigm change in the treatment of multiple sclerosis (161K)
UOA05-08: The use of alemtuzumab in stem cell and organ transplantation (153K)
UOA05-09: B vitamins can slow the disease process in early Alzheimer’s disease (171K)
UOA05-10: Mapping vector-borne diseases to inform global planning for control and elimination (157K)
UOA05-11: BEAST and Phylogenetic inference in viral disease epidemiology (156K)
UOA05-12: Revolution in influenza vaccine production (146K)
UOA05-13: Oxford BioMedica: effective tools for gene therapy (154K)
UOA05-14: Prolysis Ltd: novel methods for antibiotic discovery (156K)
UOA05-15: Oxford Gene Technology: the detection of genetic variation using microarrays (150K)
UOA05-16: BioAnaLab Limited: a contract analytical laboratory (145K)
UOA05-17: Everest Biotech Ltd: providing high quality reagents for research (151K)
UOA05-18: Transforming the welfare of commercially-reared poultry (165K)
UOA05-19: Securing the future of the globally threatened Large Blue butterfly (186K)
UOA05-20: Using honey bees as an effective deterrent for crop-raiding elephants (285K)
UOA05-22: Oral drug therapy transforms life for neonatal diabetes sufferers (166K)